| Metric | შპს ბათუმის ენდოკრინოლოგიის ცენტრი | შპს ნეოგენი | შპს სტატუსი | შპს ლოტუსი |
|---|---|---|---|---|
| Growth | ||||
| Revenue | ₾2.2m₾1.9m | ₾2.3m₾2.1m | ₾2.0m₾347k | ₾1.7m₾1.8m |
| Revenue growth | 14.1% | 8.1% | 467.6% | -3.3% |
| Profitability | ||||
| EBITDA | ₾160k₾267k | ₾208k | ||
| -₾105k-₾818k |
| ₾245k₾184k |
| EBITDA margin | 7.4%14.0% | 9.2%7.7% | -5.3%-235.7% | 14.2%10.3% |
| Net profit | ₾159k₾265k | ₾178k₾135k | -₾106k-₾800k | ₾26k₾184k |
| Net margin | 7.3%13.9% | 7.9%6.5% | -5.4%-230.5% | 1.5%10.3% |
| Balance sheet | ||||
| Total assets | ₾2.1m₾2.2m | ₾369k₾355k | ₾3.4m₾3.7m | ₾2.6m₾2.5m |
| Total equity | ₾1.9m₾2.1m | ₾230k₾221k | ₾3.3m₾3.5m | ₾1.6m₾1.6m |
| ROE | 8.2%12.7% | 77.5%61.3% | -3.2%-22.6% | 1.7%11.7% |